Stage IV Lymphoepithelioma of the Nasopharynx Completed Phase 2 Trials for Platinum (DB12257)

IndicationStatusPhase
DBCOND0029528 (Stage IV Lymphoepithelioma of the Nasopharynx)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00408694Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal CancerTreatment